Advances and Challenges of Liposome Assisted Drug Delivery

Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate

(2016) Pranatharthi Chandrasekar   Therapeutics and Clinical Risk Management

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

(2015) T. C. Chang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Are PEGylated liposomes better than conventional liposomes? A special case for vincristine

(2015) Xuling Wang et al.   DRUG DELIVERY

Liposomes as nanomedical devices

(2015) Giuseppina Bozzuto et al.   International Journal of Nanomedicine

Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue

(2015) Susan Hua et al.   Nanomedicine-Nanotechnology Biology and Medicine

Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis

(2015) Franziska Jahn et al.   ONCOLOGY

High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation

(2015) Maddalena Giannella et al.   TRANSPLANTATION

Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study

(2015) Mitsukuni Suenaga et al.   Drug Design Development and Therapy

Multifunctional nanoparticles for use in theranostic applications

(2015) James T. Cole et al.   Drug Delivery and Translational Research

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

(2014) A. Awada et al.   ANNALS OF ONCOLOGY

Nanomedicines: addressing the scientific and regulatory gap

(2014) Sally Tinkle et al.   Annals of the New York Academy of Sciences

Development of a novel liposomal nanodelivery system for bioluminescence imaging and targeted drug delivery in ErbB2-overexpressing metastatic ovarian carcinoma

(2014) XIAO-JIAN HAN et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect

(2014) Khaled Greish et al.   International Journal of Nanomedicine

Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes

(2014) Bilyana M. Dicheva et al.   JOURNAL OF CONTROLLED RELEASE

Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats

(2014) Jaap Rip et al.   JOURNAL OF DRUG TARGETING

Liposomes in tissue engineering and regenerative medicine

(2014) N. Monteiro et al.   Journal of the Royal Society Interface

Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina

(2014) Shengyong Geng et al.   NANOTECHNOLOGY

Intestinal barrier in inflammatory bowel disease

(2014) Lena Antoni   WORLD JOURNAL OF GASTROENTEROLOGY

Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

(2013) Meir Wetzler et al.   Clinical Lymphoma Myeloma & Leukemia

Pharmaceutical Development and Regulatory Considerations for Nanoparticles and Nanoparticulate Drug Delivery Systems

(2013) Ajits. Narang et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems

(2013) John C. Kraft et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Current trends in the use of liposomes for tumor targeting

(2013) Pranali P Deshpande et al.   Nanomedicine

Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection

(2013) J P Clancy et al.   THORAX

The use of lipid-based nanocarriers for targeted pain therapies

(2013) Susan Hua et al.   Frontiers in Pharmacology

Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies

(2013) Susan Hua   Frontiers in Pharmacology

Challenges in Development of Targeted Liposomal Therapeutics

(2012) Rupa R. Sawant et al.   AAPS Journal

Liposomal drug delivery systems: From concept to clinical applications

(2012) Theresa M. Allen et al.   ADVANCED DRUG DELIVERY REVIEWS

Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic

(2012) Anu Puri et al.   CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

Lipid-based carriers: manufacturing and applications for pulmonary route

(2012) Chiraz Jaafar-Maalej et al.   Expert Opinion on Drug Delivery

Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies

(2012) Régis Coco et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Cationic Thermosensitive Liposomes: A Novel Dual Targeted Heat-Triggered Drug Delivery Approach for Endothelial and Tumor Cells

(2012) Bilyana M. Dicheva et al.   NANO LETTERS

Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors

(2011) Christian Johannes Schmitt et al.   ANNALS OF HEMATOLOGY

Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial

(2011) J. M. Lohr et al.   ANNALS OF ONCOLOGY

Drug delivery systems for differential release in combination therapy

(2011) Hongbin Zhang et al.   Expert Opinion on Drug Delivery

Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy

(2011) Ming-Kung Yeh et al.   International Journal of Nanomedicine

Trigger release liposome systems: local and remote controlled delivery?

(2011) Sagida Bibi et al.   JOURNAL OF MICROENCAPSULATION

Nanotechnology and Nanomedicine: Going Small Means Aiming Big

(2010) Mahesh Kumar Teli et al.   CURRENT PHARMACEUTICAL DESIGN

Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours

(2010) Pavel S. Yarmolenko et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Nanomedicine-Challenge and Perspectives

(2009) Kristina Riehemann et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies

(2009) W. C. Zamboni et al.   CLINICAL CANCER RESEARCH

A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn

(2009) Jessica M Holmén Larsson et al.   GLYCOBIOLOGY

Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions

(2009) Janos Szebeni et al.   JOURNAL OF LIPOSOME RESEARCH

Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic Mucosa

(2009) Boaz Tirosh et al.   MOLECULAR PHARMACEUTICS

Translational nanomedicine: status assessment and opportunities

(2009) James S. Murday et al.   Nanomedicine-Nanotechnology Biology and Medicine

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel

(2008) G. J. Fetterly et al.   CLINICAL CANCER RESEARCH

Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics

(2008) Robert B. Campbell et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes

(2007) Tatsuhiro Ishida et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS